Myrexis Stock Price, News & Analysis (OTCMKTS:MYRX)

$0.04 0.01 (33.90 %)
(As of 12/15/2017 04:00 PM ET)
Previous Close$0.03
Today's Range$0.03 - $0.04
52-Week Range$0.03 - $0.10
Volume98,933 shs
Average Volume1,322 shs
Market Capitalization$1.07 million
P/E RatioN/A
Dividend YieldN/A
Beta0.25

About Myrexis (OTCMKTS:MYRX)

Myrexi, Inc. is a development-stage company. The Company was a biopharmaceutical company that generated a pipeline of differentiated drug candidates in oncology and autoimmune diseases. In February 2012, it announced that the Company has suspended development activity on all of its preclinical and clinical programs and retained Stifel Nicolaus Weisel, an investment banking firm, to assist in reviewing and evaluating a full range of strategic alternatives to enhance shareholder value. The Company determines to pursue the acquisition of one or more commercial-stage biopharmaceutical assets, with the goal of building a commercial-stage biopharmaceutical company. The Company operates in pharmaceutical development and related research activities. The Company’s revenues were derived from research performed in the United States and, all of the Company’s long-lived assets are located in the United States.

Receive MYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MYRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs - Generic
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:MYRX
CUSIPN/A
Phone801-214-7800

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares34,480,000

Myrexis (OTCMKTS:MYRX) Frequently Asked Questions

What is Myrexis' stock symbol?

Myrexis trades on the OTCMKTS under the ticker symbol "MYRX."

Who are some of Myrexis' key competitors?

Who are Myrexis' key executives?

Myrexis' management team includes the folowing people:

  • Jonathan M. Couchman, President, Chief Executive Officer, Chief Financial Officer, Director (Age 45)
  • Andrea Kendell, Treasurer, Secretary (Age 40)
  • Michael Cooper Pearce, Independent Director (Age 51)
  • Steven D. Scheiwe, Independent Director (Age 55)

How do I buy Myrexis stock?

Shares of Myrexis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Myrexis' stock price today?

One share of Myrexis stock can currently be purchased for approximately $0.04.

How big of a company is Myrexis?

Myrexis has a market capitalization of $1.07 million.

How can I contact Myrexis?

Myrexis' mailing address is C/O XSTELOS HOLDINGS INC. 630 FIFTH AVENUE SUITE 2260, NEW YORK NY, 10020. The biopharmaceutical company can be reached via phone at 801-214-7800 or via email at [email protected]


MarketBeat Community Rating for Myrexis (MYRX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  18 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  31
MarketBeat's community ratings are surveys of what our community members think about Myrexis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Myrexis (OTCMKTS:MYRX) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Myrexis (OTCMKTS:MYRX)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Myrexis (OTCMKTS:MYRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Myrexis (OTCMKTS:MYRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/25/2013special$2.862/19/20132/4/20132/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Myrexis (OTCMKTS MYRX)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Myrexis (OTCMKTS MYRX) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Myrexis (OTCMKTS:MYRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Myrexis (OTCMKTS:MYRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Myrexis (OTCMKTS MYRX) Stock Chart for Saturday, December, 16, 2017

Loading chart…

This page was last updated on 12/16/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.